FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:1601-1613 April 13, 2006 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Trans fats, unsaturated fatty acids with at least one double bond in the trans configuration (Figure 1), are formed during the partial hydrogenation of vegetable oils, a process that converts vegetable oils into semisolid fats for use in margarines, commercial cooking, and manufacturing processes. From the perspective of the food industry, partially hydrogenated vegetable oils are attractive because of their long shelf life, their stability during deep-frying, and their semisolidity, which can be customized to enhance the palatability of baked goods and sweets. The average consumption of industrially produced trans fatty acids in the United States is 2 . . . [Full Text of this Article]

Physiological Effects of Trans Fatty Acids

Serum Lipids

Systemic Inflammation

Endothelial-Cell Function

Other Effects

Potential Molecular Mechanisms

Intake of Trans Fat and Cardiovascular Disease

CHD

Sudden Death from Cardiac Causes

Diabetes

Trans Fatty Acids from Ruminants

Reducing Intake of Trans Fatty Acids

Optimal Levels

Consumers' Choices

Industry Alternatives

Potential Benefits of Reducing Intake

Conclusions

Source Information

From the Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, and the Departments of Nutrition and Epidemiology, Harvard School of Public Health — all in Boston (D.M., A.A., M.J.S., W.C.W.); and the Division of Human Nutrition, Wageningen University, and Wageningen Center for Food Sciences — both in Wageningen, the Netherlands (M.B.K.).

Address reprint requests to Dr. Mozaffarian at the Harvard School of Public Health, 665 Huntington Ave., Bldg. 2, Rm. 315, Boston, MA 02115, or at dmozaffa@hsph.harvard.edu.

This article has been cited by other articles:

• McColl, K. (2008). New York's road to health. BMJ 337: a673-a673 [Full Text]  
• Mozaffarian, D., Wilson, P. W.F., Kannel, W. B. (2008). Beyond Established and Novel Risk Factors: Lifestyle Risk Factors for Cardiovascular Disease. Circulation 117: 3031-3038 [Full Text]  
• Frieden, T. R, Bassett, M. T, Thorpe, L. E, Farley, T. A (2008). Public health in New York City, 2002-2007: confronting epidemics of the modern era. Int J Epidemiol 0: dyn108v1-dyn108 [Abstract] [Full Text]  
• Bassuk, S. S., Manson, J. E. (2008). Lifestyle and Risk of Cardiovascular Disease and Type 2 Diabetes in Women: A Review of the Epidemiologic Evidence. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2: 191-213 [Abstract]  
• Chajes, V., Thiebaut, A. C. M., Rotival, M., Gauthier, E., Maillard, V., Boutron-Ruault, M.-C., Joulin, V., Lenoir, G. M., Clavel-Chapelon, F. (2008). Association between Serum trans-Monounsaturated Fatty Acids and Breast Cancer Risk in the E3N-EPIC Study. Am J Epidemiol 167: 1312-1320 [Abstract] [Full Text]  
• Marchesini, G., Ridolfi, V., Nepoti, V. (2008). Hepatotoxicity of fast food?. Gut 57: 568-570 [Full Text]  
• Willett, W., Mozaffarian, D. (2008). Ruminant or industrial sources of trans fatty acids: public health issue or food label skirmish?. Am. J. Clin. Nutr. 87: 515-516 [Full Text]  
• Chardigny, J.-M., Destaillats, F., Malpuech-Brugere, C., Moulin, J., Bauman, D. E, Lock, A. L, Barbano, D. M, Mensink, R. P, Bezelgues, J.-B., Chaumont, P., Combe, N., Cristiani, I., Joffre, F., German, J B., Dionisi, F., Boirie, Y., Sebedio, J.-L. (2008). Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am. J. Clin. Nutr. 87: 558-566 [Abstract] [Full Text]  
• Motard-Belanger, A., Charest, A., Grenier, G., Paquin, P., Chouinard, Y., Lemieux, S., Couture, P., Lamarche, B. (2008). Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am. J. Clin. Nutr. 87: 593-599 [Abstract] [Full Text]  
• Mozaffarian, D. (2008). Commentary: Ruminant trans fatty acids and coronary heart disease--cause for concern?. Int J Epidemiol 37: 182-184 [Full Text]  
• Chavarro, J. E., Stampfer, M. J., Campos, H., Kurth, T., Willett, W. C., Ma, J. (2008). A Prospective Study of Trans-Fatty Acid Levels in Blood and Risk of Prostate Cancer. Cancer Epidemiol. Biomarkers Prev. 17: 95-101 [Abstract] [Full Text]  
• Merchant, A. T, Kelemen, L. E, de Koning, L., Lonn, E., Vuksan, V., Jacobs, R., Davis, B., Teo, K. K, Yusuf, S., Anand, S. S, for the SHARE and SHARE-AP investigators, (2008). Interrelation of saturated fat, trans fat, alcohol intake, and subclinical atherosclerosis. Am. J. Clin. Nutr. 87: 168-174 [Abstract] [Full Text]  
• Getz, G. S., Reardon, C. A. (2007). Nutrition and Cardiovascular Disease. Arterioscler. Thromb. Vasc. Bio. 27: 2499-2506 [Abstract] [Full Text]  
• Kim, D. H. (2007). High-Density Lipoprotein and Dietary Fatty Acids. JAMA 298: 2263-2264 [Full Text]  
• Singh, I. M., Shishehbor, M. H., Ansell, B. J. (2007). High-Density Lipoprotein and Dietary Fatty Acids Reply. JAMA 298: 2264-2264 [Full Text]  
• Tomey, K. M., Sowers, M. R., Li, X., McConnell, D. S., Crawford, S., Gold, E. B., Lasley, B., Randolph, J. F. Jr (2007). Dietary Fat Subgroups, Zinc, and Vegetable Components Are Related to Urine F2a-Isoprostane Concentration, a Measure of Oxidative Stress, in Midlife Women. J. Nutr. 137: 2412-2419 [Abstract] [Full Text]  
• Sun, Q., Ma, J., Campos, H., Hu, F. B (2007). Plasma and erythrocyte biomarkers of dairy fat intake and risk of ischemic heart disease. Am. J. Clin. Nutr. 86: 929-937 [Abstract] [Full Text]  
• Okie, S. (2007). New York to Trans Fats: You're Out!. NEJM 356: 2017-2021 [Full Text]  
• Hendry, J. (2007). Experts Weigh In: Will Trans Fat Bans Affect Obesity Trends?. DOC News 4: 1-20 [Full Text]  
• Eckel, R. H., Borra, S., Lichtenstein, A. H., Yin-Piazza, S. Y. (2007). Understanding the Complexity of Trans Fatty Acid Reduction in the American Diet: American Heart Association Trans Fat Conference 2006: Report of the Trans Fat Conference Planning Group. Circulation 115: 2231-2246 [Abstract] [Full Text]  
• Sun, Q., Ma, J., Campos, H., Hankinson, S. E., Manson, J. E., Stampfer, M. J., Rexrode, K. M., Willett, W. C., Hu, F. B. (2007). A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease. Circulation 115: 1858-1865 [Abstract] [Full Text]  
• Hendry, J. (2006). Differentiating Food Fats. DOC News 3: 10-11 [Full Text]  
• Lichtenstein, A. H. (2006). Thematic review series: Patient-Oriented Research. Dietary fat, carbohydrate, and protein: effects on plasma lipoprotein patterns. J. Lipid Res. 47: 1661-1667 [Abstract] [Full Text]  
• Clarke, R., Lewington, S. (2006). Trans fatty acids and coronary heart disease. BMJ 333: 214-214 [Full Text]  
• Spollett, G. R. (2006). Disease Stressors More Difficult to Recognize and Define. DOC News 3: 6-6 [Full Text]